Effects of Semaglutide on Cardiac Protein Expression and Cardiac Function of Obese Mice
Xiaoyu Pan,1,2 Lin Yue,1,2 Jiangli Ban,2 Lin Ren,2 Shuchun Chen1,2 1Department of Internal Medicine, Hebei Medical University, Shijiazhuang, People's Republic of China; 2Department of Endocrinology, Hebei General Hospital, Shijiazhuang, People's Republic of ChinaCorrespondence: Shuchun Che...
Saved in:
Main Authors: | Pan X (Author), Yue L (Author), Ban J (Author), Ren L (Author), Chen S (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolomics Provides Insights into Renoprotective Effects of Semaglutide in Obese Mice
by: Chen X, et al.
Published: (2022) -
Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice
by: Xiaoyi Chen, et al.
Published: (2023) -
An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism
by: Ren Q, et al.
Published: (2022) -
Semaglutide Reduces Cardiomyocyte Damage Caused by High-Fat Through HSDL2
by: Yang L, et al.
Published: (2024) -
Semaglutide for the treatment of obesity
by: Rafał Oleszczuk, et al.
Published: (2022)